Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children

Saudi Medical Journal

Volumn 31, Issue 4, 2010, Pages 461-462

  Al Mendalawi, Mahmood D ^a   Bukhari, Elham ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM DETECTION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HOSPITAL; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; SAUDI ARABIA; SENSITIVITY AND SPECIFICITY; SKIN INFECTION; UNITED STATES; CHILD; COMMUNICABLE DISEASE; NOTE; STAPHYLOCOCCUS INFECTION;

CHILD; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SAUDI ARABIA; STAPHYLOCOCCAL INFECTIONS;

EID: 77956022429     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Bukhari EE, Al-Otaibi FE. Severe community-acquired infection caused by methicillin-resistant Staphylococcus aureus in Saudi Arabian children. Saudi Med J 2009; 30: 1595-1600.
2. Lawrence KR, Golik MV, Davidson L. The role of primary care subscribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Am J Ther 2009; 16: 333-338.
3. Bassetti M, Nicco E, Mikulska M. Why is community-associated MRSA spreading across the world and how will it change clinical practice? Int J Antimicrob Agents 2009; 34 Suppl 1: S15-S19.
4. Miller LG, Perdreau-Remington F, Bayer AS, Diep B, Tan N, Bharadwa K, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44: 471-482.